title: Response to letter to the editor: Strategies to reduce HCV disease burden and HCV transmission need different models, as what works for end-stage liver disease may not work for HCV prevalence: a comment on the results presented in JVH Special Issue.
authors.affiliation: Center for Disease Analysis, Louisville, CO, USA. homie.razavi@centerforda.com.
authors.forename: H
authors.initials: H
authors.lastname: Razavi
authors.forename: P
authors.initials: P
authors.lastname: Bruggmann
authors.forename: H
authors.initials: H
authors.lastname: Wedemeyer
authors.forename: G
authors.initials: G
authors.lastname: Dore
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000453:epidemiology*; D006801:Humans; D008297:Male
chemical_list: D000998:Antiviral Agents